Stroke Net Grand Round Webinar

Similar documents
HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

Subclavian artery Stenting

Latest Advances in the Neurointerventional Treatment of Ischemic Stroke P A C I F I C N E U R O. O R G

a. Ischemic stroke An acute focal infarction of the brain or retina (and does not include anterior ischemic optic neuropathy (AION)).

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre

Advances in Neuro-Endovascular Care for Acute Stroke

CEREBRO VASCULAR ACCIDENTS

COMPREHENSIVE SUMMARY OF INSTOR REPORTS

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Remote ischemic conditioning in the STEMI and stroke: are we ready for clinical implementation?

Nicolas Bianchi M.D. May 15th, 2012

Guideline scope Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (update)

Improving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark

Interventional Neuroradiology. & Stroke INR PROCEDURES INR PROCEDURES. Dr Steve Chryssidis. 25-Sep-17. Interventional Neuroradiology

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

Vascular surgery is a specialty that deals with diseases of the vascular system (i.e. arteries, veins

Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Chapter 4 Section 9.1

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

Stroke Update. Claire J. Creutzfeldt, MD January 12, 2018

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke

Comparison of Five Major Recent Endovascular Treatment Trials

(For items 1-12, each question specifies mark one or mark all that apply.)

TIA: Updates and Management 2008

Continuing Medical Education Post-Test

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure

Cardiovascular Disease

ESM 1. Survey questionnaire sent to French GPs. Correct answers are in bold. Part 2: Clinical cases: (Good answer are in bold) Clinical Case 1:

Basilar artery stenosis with bilateral cerebellar strokes on coumadin

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion

Alan Barber. Professor of Clinical Neurology University of Auckland

Chapter 4 Section 9.1

PFO Management update

Stroke: What did we learn in the last year?

ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

UPDATES IN INTRACRANIAL INTERVENTION Jordan Taylor DO Metro Health Neurology 2015

Practical Considerations in the Early Treatment of Acute Stroke

The Muscatine Study Heart Health Survey

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

framework for flow Objectives Acute Stroke Treatment Collaterals in Acute Ischemic Stroke framework & basis for flow

Background. Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE

The Impact of Smoking on Acute Ischemic Stroke

Supplementary Online Content

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Stroke Update Elaine J. Skalabrin MD Medical Director and Neurohospitalist Sacred Heart Medical Center Stroke Center

The DAWN of a New Era for Wake-up Stroke

Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.

Master Eudipharm 2012 Introductory Module, Principles of Discovery of Medicine and Development Planning. Nathan Mewton, MD, PhD. September 26 th 2012

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Pathophysiology of ischemia-reperfusion injury (and how to protect against it )

FastTest. You ve read the book now test yourself

7/18/2018. Cerebral Vasospasm: Current and Emerging Therapies. Disclosures. Objectives

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease

MINIMALLY-INVASIVE TREATMENT OF VASCULAR DISEASE

National Vascular Registry

Carotid Revascularization

The learning curve associated with intracranial angioplasty and stenting: analysis from a single center

National Vascular Registry

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

Coordination and Regionalization of Acute Care: What about stroke?

Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective

TENNESSEE STROKE REGISTRY QUARTERLY REPORT

Corporate Medical Policy

Vascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2)

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

Peripheral Vascular Disease

11/1/2018. Disclosure. Imaging in Acute Ischemic Stroke 2018 Neuro Symposium. Is NCCT good enough? Keystone Heart Consultant, Stock Options

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

2/7/

Myocardial Infarction In Dr.Yahya Kiwan

How would you manage Ms. Gold

TCD AND VASOSPASM SAH

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

Management of Acute Ischemic Stroke. Learning Objec=ves. What is a Stroke? Jen Simpson Neurohospitalist

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

NEWS ON ISCHEMIC HEART DISEASE AT THE ESC 2018 CONGRESS MARIO MARZILLI, MD, PhD

Intracranial Atherosclerosis in Asians

Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion

Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship

Current Clinical Trials for Stroke Survivors in NJ and Philadelphia Areas

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Alma Mater Studiorum Università di Bologna

5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016

Chapter 4 Section 9.1

Imaging Acute Stroke and Cerebral Ischemia

Transcription:

Stroke Net Grand Round Webinar Preconditioning the Brain for Stroke Prevention April 4, 2019 Sebastian Koch University of Miami Department of Neurology

None

Unique challenges in brain conditioning Review clinical studies of brain conditioning Translational issues for interventional studies Discuss our efforts

Is it possible to precondition the brain? Least accessible organ. Blood brain barrier? Patients with cerebrovascular disease tend to be older. Problems with conditioning the aged brain?

Pre-myocardial angina may improve cardiac outcomes. (Lorgis 2012) Reduced troponin elevation Arrhythmia Fewer ST segment changes Mortality Does TIA prior to stroke have a preconditioning effect?

TIA prior to ischemic stroke lessens stroke severity and improves functional outcome: Even if TIA occurred several years prior to index stroke. (Weih 1999) Moncayo 2000 Lausanne Stroke Registry data in over 2000 patients. Looked at duration and timing of TIAs. TIAs lasting 10-20min improved outcome when compared to TIAs lasting <10min, or 20-40min. TIAs <1 week from stroke more protective than TIAs between 1 week- 1 month, or >1 month before index stroke.

Benefit on imaging outcomes as well: Assessed the effects of TIA within 72h of index stroke. Reduced infarct volume at 4-7 days by brain CT. Better functional outcome at 90 days. Correlated protection from TIA with a higher TNFα/IL 6. (Castillo 2003)

But not a consistent finding: Northern California TIA study No effect of prior TIA on stroke outcome and disability. Even when assessing different durations of TIA and interval to index stroke Unable to confirm the protective effects of TIA on stroke severity (Johnston 2004)

Translational Challenges for Interventional Studies

Preclinical studies: young animals. healthy. free of medications. Clinical medicine: older patients. with comorbidities. on medications.

No preconditioning effect of TIA was demonstrated in elderly (>65 years) patients with stroke. (Della Morte 2008) Preclinical models of aged hearts have shown a reduction of the preconditioning effect. (Abete 1996)

Acute dosing of lovastatin aborted a preconditioning effect in rat myocardial ischemia model but did not affect postconditioning. Chronic lovastatin use did not affect preconditioing but affected postconditioning. (Kocsis 2008)

What method of conditioning? Direct conditioning impractical. Limb conditioning. Which Limb? Pharmacological conditioning?

Hauseloy 2007: 3 x 5min arm conditioning cycles prior to CABG in 57 patients. 30% reduction in post-operative troponin elevation.

Trial Clinical Setting Intervention Cardiac Cheung 2006 Pediatric cardiac surgery 2 cycles of 5 min leg ischemia Hausenloy 2007 Coronary bypass 3 cycles of 5 min arm ischemia Ali 2007 Abdominal aneurysm repair 2 cycles of 10 min iliac artery occlusion Hoole 2009 Coronary angioplasty 3 cycles of 5 min arm ischemia Rahman 2010 Coronary bypass 3 cycles of 5 min arm ischemia Thielman 2010 CABG Surgery 3 cycles of 5 min arm ischemia Wagner 2010 CABG Surgery 3 cycles of 5 min arm ischemia Ali 2010 CABG Surgery 3 cycles of 5 min arm ischemia Hong 2012 Off pump CABG Surgery 4 cycles of 5 min arm ischemia

Carotid endarterectomy or stenting. Subarachnoid hemorrhage. Coronary artery bypass. Secondary prevention in high risk patients with TIA/stroke.

Acute cerebral infarction. Cardiac arrest?

Walsh 2010 & Zhao 2017 Carotid intervention Koch 2011, Gonzalez 2013 Subarachnoid hemorrhage. Meng 2012 & 2015 Symptomatic Intracranial disease. Hougard 2013 Ischemic stroke and tpa.

Zhao 2017: 139 participants with high grade carotid stenosis Preconditioned for 2 weeks prior to carotid stenting 5x 5min cycles of arm conditioning, twice daily MRI after showed reduction in lesion volume and number of new lesions (RR~40%) No difference in clinical outcomes (but very low event rates)

Koch 2012: Subjects with aneurysmal SAH Leg preconditioning every other day from day 4-14 To ameliorate delayed cerebral ischemia Safety and feasibility study Escalating durations of limb ischemia 5, 7.5 and 10minutes 2 DVTs in leg preconditioning group Safe, feasible and tolerated

Gonzalez 2013: Subjects with aneurysmal SAH. Leg preconditioning 4x 5min every other day from day 2-12. Assessed metabolic and hemodynamic effects. TCD, microdialysis. Transient vasodilation with decrease in MCA TCD velocities. Reduction of lactate/pyruvate ratio and glycerol for up to 2 days.

Meng 2012 68 patients with symptomatic intracranial stenosis. 5 cycles x 5 min arm conditioning twice daily for 300 days vs. control group. Outcomes: recurrent stroke, mrs, TCD and SPECT at 90 and 300 days. Recurrent stroke at 90 days: 5% vs. 23% (p<0.01) Improved functional recovery by mrs 0-1 (p<0.01) Improved cerebral perfusion by SPECT. Improved TCD blood flow velocities.

Hougaard 2013: Randomized 453 stroke patients who received IV tpa. 3x 5 min arm conditioning cycles with start in ambulance. Primary endpoint: volume of tissue in PWI/DWI mismatch not progressing to infarction No evidence of effect on penumbral salvage and final infarct volume No difference in clinical outcomes at 3 months But reduced the amount of tissue at risk of infarction Reduced admission NIHSS in conditioned subjects (p=0.016). More TIAs in conditioned group (p=0.006).

Proof on concept and exploratory Signal of efficacy Intervention is safe Currently ongoing larger studies in acute ischemic stroke (France, Denmark), and secondary stroke prevention in intracranial disease (China)

Extent of preclinical evidence Shown in multiple organ systems Innovation of approach to cytoprotection Preconditioning Post-and Perconditioning +++ + +++ + +++ + Clinical applicability + +++

Subarachnoid hemorrhage Carotid artery stenting / endarterectomy Cardiac bypass Secondary stroke prevention Favorable patient demographics +++ + + + Ischemic risk over time +++ 20% ++ 3-6% + ~2% + 8% Preconditioning length ++ 14 days +++ One time +++ One time + Months Model for ischemia + +++ ++ +++

Subarachnoid Hemorrhage 1 Coronary artery bypass surgery 2 Carotid endarterecotmy 3 Secondary Stroke Prevention 4 Age (years) 53 ±12 67* 68* 60± 9 Hypertension (%) 42 61 62 29 Smoking (%) 48 65 21 30 Diabetes (%) 3 42 21 24 Ischemic heart disease (%) 1 100 23 Not available 1 Koch 2012; 2 Hausenloy 2007; 3 Walsh 2010; 4 Meng 2012 Modified from Koch 2013

Subarachnoid hemorrhage Carotid artery stenting / endarterectomy Cardiac bypass Secondary stroke prevention Favorable patient demographics +++ + + + Ischemic risk over time +++ 20% ++ 3-6% + ~2% + 8% Preconditioning Duration ++ 14 days +++ One time +++ One time + Months Model for ischemia + +++ ++ +++

Safety and Feasibility in SAH Biomarker Exploratory Aim Serum marker, MRI outcomes 4 x 5min cycles vs. 3x 10min vs. sham Sample size 150 participants, 10 sites

Murry 1986 direct preconditioning. Przylenk 1993 regional, remote preconditioning. 400 BC Hippocrates- prescribed small doses of mandrake root, which causes mania, to treat mania. 16 th Paracelsus- what makes a man ill also cures him. 18 th century- Samuel Hahneman. Diseases should be treated by drugs that cause similar symptoms in humans. 19 th Nietzsche- what does not kill me makes me stronger.